An RF network and a dual-tuned surface coil are described for obtaining proton-decoupled, NOE enhanced 19F spectra from a whole body clinical imager operating at 1.5 Tesla. The network removes 19F frequency noise from the decoupler transmitter and prevents preamplifier saturation from high- level decoupling signals. Proton decoupling of 19F spectra was optimized using a sample of urine containing 5-fluorouracil (5-FU) and its catabolite fluoro-β-alanine (FBAL). Proton-decoupled 19F spectroscopy in vivo is demonstrated by obtaining both nonlocalized spectra and spectra localized with three-dimensional chemical shift imaging from the liver of patients undergoing 5-FU chemotherapy.
CITATION STYLE
Murphy-Boesch, J., Li, C. W., He, L., Padavic-Shaller, K. A., Negendank, W., & Brown, T. R. (1997). Proton-decoupled 19F spectroscopy of 5-FU catabolites in human liver. Magnetic Resonance in Medicine, 37(3), 321–326. https://doi.org/10.1002/mrm.1910370302
Mendeley helps you to discover research relevant for your work.